Douglas Fir Allergy Shots: Not a Fir, Not a Pine — Know the Difference
Douglas fir (Pseudotsuga menziesii) is the iconic Pacific Northwest conifer — genus Pseudotsuga, not Pinus and not Abies — covering 35% of Oregon and Washington forest volume. It releases pollen in April–June, but Thermo Fisher's ImmunoCAP product notes it is 'not considered a major urban aeroallergen.' In the PNW, red alder (Alnus rubra) with its Bet v 1 cross-reactivity is the dominant spring tree allergen.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Douglas Firis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Douglas Fir Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to douglas fir — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of douglas fir allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of douglas fir immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of douglas fir extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for douglas fir allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing douglas fir extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription douglas fir immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat douglas fir allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Douglas Fir?
The biology, taxonomy, and clinical fingerprint of Douglas Fir — the foundation of how SCIT targets it.
Douglas fir (Pseudotsuga menziesii) releases saccate pollen grains of 80–110 μm in April–June across PNW forests, but is not considered a major urban aeroallergen — red alder drives most PNW spring tree allergy.
- Scientific name
- Pseudotsuga menziesii
- Family
- PinaceaePine family
- Type
- Conifer tree pollen — distinct genus Pseudotsuga within Pinaceae
- Native to
- Pacific Coast ranges and Cascades of Oregon, Washington, and British Columbia; also Rockies as var. glauca
- Allergen proteins
- No IUIS-named allergen registered for Pseudotsuga menziesii; Thermo Fisher ImmunoCAP code t207 available but described as 'anecdotal allergic rhinitis and asthma; not a major urban aeroallergen'
- Particle size
- 80–110 μm (saccate, two air sacs — similar to true Pinus)
- Avoidance difficulty
- Very difficult
How Douglas Fir Allergy Presents
Symptoms by body system — useful for distinguishing Douglas Fir sensitivity from overlapping allergies and infections.
Respiratory
- Seasonal rhinitis with onset April–June in PNW communities surrounded by Douglas fir forest
- Nasal congestion coinciding with visible pollen release from fir catkins
- Mild asthma exacerbation in anecdotally reported Pseudotsuga-sensitized individuals
- Symptom misattribution to fir — red alder's Bet v 1 protein typically drives PNW spring respiratory allergy
Ocular
- Itchy, watery eyes during April–June outdoor exposure in fir-dominated PNW forests
- Conjunctival redness after prolonged forest walks during pollen release
- Mild eyelid swelling in sensitized individuals
Dermal
- Contact urticaria from direct Douglas fir pollen contact (anecdotal; not documented in clinical literature)
- Skin irritation from fir resin — distinct from IgE-mediated pollen allergy
- Occupational dermatitis from fir lumber handling in forestry workers
Systemic
- Fatigue from disrupted sleep during PNW spring pollen season
- Reduced outdoor activity in the heavily forested Pacific Northwest landscape
- Symptom overlap with concurrent red alder and grasses — the most common PNW spring sensitizers
Doug fir is the symbol of the Pacific Northwest, but in our Seattle and Portland clinics the patients who think they're allergic to fir are almost always reacting to red alder, which peaks just before Doug fir and shares the Bet v 1 family with birch. Test for alder first.
When & Where Douglas Fir Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: April–June in the PNW coastal belt; interior Rocky Mountain var. glauca may peak May–July· Approximately 8–10 weeks of pollen release; preceded by red alder season (February–March) in the PNW
US Exposure Map
2 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- High
- MT:
- Moderate
- ND:
- Low
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- High
- ID:
- Moderate
- WY:
- Low
- SD:
- Low
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Low
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Moderate
- NV:
- Low
- UT:
- Low
- CO:
- Low
- NE:
- Low
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- Low
- NM:
- Low
- KS:
- Low
- AR:
- Low
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- Low
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- Low
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Douglas Fir Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Douglas fir (Pseudotsuga) has partial but not complete cross-reactivity with Pinus species — they share Pinaceae family membership but belong to different genera, meaning separate IgE testing is needed for accurate SCIT vial composition.
Partial intra-Pinaceae cross-reactivity; not complete enough to substitute pine extract for Pseudotsuga
Is SCIT Right for Your Douglas Fir Allergy?
Answer five questions to assess whether Douglas fir allergy shots are the right immunotherapy target for your PNW spring symptoms.
How severe are your spring pollen symptoms during April–June in the Pacific Northwest?
The Douglas Fir SCIT Protocol
When Douglas fir SCIT is prescribed for a confirmed Pseudotsuga-sensitized patient, it uses a separate non-standardized extract — not a pine-mix vial — because cross-reactivity with Pinus is only partial.
Weekly injections escalate the Pseudotsuga menziesii extract over 16–24 weeks from a dilute starting concentration to maintenance dose. Because Douglas fir cross-reactivity with pine extracts is only partial, your allergist will typically use a separate fir extract rather than relying on a pine-mix vial. With Curex, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff, and a prescribed epinephrine auto-injector is confirmed on hand.
Maintenance injections at the target maintenance concentration, on a schedule set by the prescribing allergist. Lot-to-lot variability in this non-standardized extract warrants dose review when new vials are opened. PNW patients may also need red alder SCIT in a concurrent vial set if alder sensitization is confirmed.
After completing the standard course, clinical response guides the decision to continue or discontinue. No Pseudotsuga-specific trial data inform this endpoint — it is based on symptom trajectory and shared decision-making.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Douglas Fir SCIT
No randomized controlled trial has been published for Douglas fir SCIT — the evidence is limited to anecdotal case reports and product catalog notes classifying it as a non-major urban aeroallergen.
- Douglas fir described as 'not a major urban aeroallergen'15%Thermo Fisher Scientific — ImmunoCAP t207 product literature
- Low PNW SPT positivity in early sensitivity series12%Andrews JL, Bardana EJ, Ann Allergy, 1982, N=PNW cohort
- Inhalant SCIT symptom reduction (class-level extrapolation only)55%Cox L et al., JACI, 2011 — AAAAI Practice Parameter meta-summary
Douglas fir SCIT has no published RCT and is classified by major diagnostic labs as a non-major urban aeroallergen. For PNW patients with spring symptoms, red alder (Alnus rubra) sensitization — with its Bet v 1 cross-reactivity documented across Fagales — is a far more common clinical finding. Testing should confirm Pseudotsuga-specific IgE before fir SCIT is prescribed.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Douglas Fir SCIT Side Effects
Douglas fir SCIT carries the standard inhalant SCIT side-effect profile. No Pseudotsuga-specific safety signals have been identified, consistent with the overall rarity of this SCIT indication.
Local reactions
3 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Most common; resolves within hours | Rate 30–50% | Mild |
Injection-site redness and itching More frequent at concentration step-ups | Rate 20–40% | Mild |
Large local reaction (>5 cm) May prompt dose reduction; not predictive of systemic reaction | Rate 5–15% | Moderate |
Systemic reactions
3 documented| Reaction | Rate | Severity |
|---|---|---|
Generalized urticaria Curex confirms a prescribed epinephrine auto-injector on hand and supervises the first injection from each new vial or concentration live in the Virtual Shot Room | Rate <1% | Moderate |
Rhinitis or conjunctivitis flare Temporary post-injection exacerbation | Rate 1–3% | Mild |
Anaphylaxis Curex supervises the first injection from each new vial or concentration live in the Virtual Shot Room with a prescribed epinephrine auto-injector confirmed on hand | Rate <0.01% per injection | Severe |
Systemic reactions, when they occur, typically begin within about 30 minutes of an injection — true for all inhalant SCIT, including Douglas fir. With Curex at-home SCIT, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff, and a prescribed epinephrine auto-injector is confirmed on hand before the first injection. No Pseudotsuga-specific safety signals differentiate fir SCIT from other non-standardized tree extracts.
SCIT vs Alternatives for Douglas Fir
For PNW patients with confirmed Douglas fir sensitization, SCIT, sublingual drops, avoidance strategies, and daily medications are the main options — with the additional note that red alder SCIT may be more clinically important to address simultaneously.
| Criterion | At-Home SCIT (Curex)Best | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Low-moderate (anecdotal data only; no RCT) | Emerging; no Douglas fir-specific trial | Limited — unavoidable in PNW forests | Symptomatic relief only |
| 5-yr cost | $3,500–$15,000 | Daily drops (varies by pharmacy) | Low | $500–$2,000/year |
| Duration | 3–5 years | 3–5 years | Ongoing | Indefinite |
| Convenience | At-home self-injection; weekly during build-up | Daily drops at home | HEPA filters; windows closed April–June | Daily pills/sprays |
| Safety | Virtual Shot Room–supervised dosing + prescribed epi | Lower systemic reaction risk vs SCIT | Safe | Safe; antihistamine sedation risk |
| Lasting effect | Possible lasting tolerance | Possible lasting benefit | No immune modification | No lasting effect |
At-Home SCIT (Curex)Best
SLIT
Avoidance
Medications
In the rare confirmed Douglas fir monosensitization case where patients live in remote PNW communities, Curex now delivers SCIT as an at-home allergy shot with pricing confirmed in a current program quote: a Pseudotsuga serum compounded under USP <797>, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen escalation — a remote-friendly home-based path that avoids weekly clinic visits in areas with limited specialty allergy access.
What Douglas Fir SCIT Actually Costs
Most major insurers cover inhalant SCIT under standard allergy benefits when ordered by a board-certified allergist. Douglas fir extract is non-standardized and this is an uncommon prescription, so prior authorization and documentation of confirmed sensitization is particularly important. Verify coverage before initiating. Curex at-home IgE testing identifies specific douglas fir sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your douglas fir allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Douglas Fir SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Neither. Douglas fir (Pseudotsuga menziesii) is its own genus — Pseudotsuga — within the Pinaceae family but is not a true fir (Abies), a true pine (Pinus), or a spruce (Picea). The genus Pseudotsuga was established by Carrière in 1867. The name 'Douglas fir' is a historical common name honoring botanist David Douglas; it is taxonomically misleading. For allergy purposes, this matters because cross-reactivity with Pinus extracts is partial rather than complete — your allergist should prescribe a separate Pseudotsuga-specific extract rather than assuming full coverage from a pine-mix vial.
Red alder (Alnus rubra) is the dominant spring tree allergen in Seattle and Portland. Red alder blooms in February–March — before Douglas fir releases pollen — and carries Bet v 1-family allergens (the same PR-10 protein family as birch, hazel, and hornbeam) that sensitize a large proportion of PNW residents. Seattle and Portland NAB station data consistently show red alder as the dominant tree pollen in the late winter and early spring period when PNW tree-allergy symptoms are most common. A board-certified allergist should test for red alder alongside Douglas fir for any PNW patient with spring respiratory symptoms.
Partially, but not fully. Pine-mix vials leverage near-complete intra-Pinus cross-reactivity, but Pseudotsuga is a separate Pinaceae genus with only partial cross-reactivity to Pinus species. No published RAST inhibition study demonstrates complete cross-protection between Pinus and Pseudotsuga. If your allergist's testing confirms Douglas fir sensitization, they will typically prescribe a separate Pseudotsuga extract rather than relying on pine-mix coverage. This is a key distinction from other Pinaceae members where cross-reactivity within the genus is essentially complete.
Timing is the first clue: red alder (Alnus rubra) peaks in February–March in the PNW, while Douglas fir releases pollen in April–June. If your symptoms worsen in late winter before Douglas fir pollen is measurable, red alder is the more likely driver. The definitive test is a specific IgE panel ordered by a board-certified allergist — separate skin test or ImmunoCAP results for red alder (Alnus rubra) and Douglas fir (Pseudotsuga menziesii t207) will clarify which species, if either, is causing your IgE response. Most PNW patients with confirmed tree-pollen sensitization show alder-predominant IgE.
Most major US health insurers cover inhalant SCIT under standard allergy benefits when ordered by a board-certified allergist with documented sensitization. Douglas fir extract is non-standardized and is an uncommon prescription — prior authorization with documented Pseudotsuga-specific IgE test results is advisable. Some PNW plans may request documentation that red alder SCIT has been considered or co-prescribed before authorizing fir-specific extract. CPT codes 95115, 95117, and 95165 are standard. Specialty allergy access varies across Oregon and Washington beyond Portland and Seattle — confirm in-network status before starting.
Yes — antihistamines can be taken during Douglas fir SCIT and are often recommended before injection visits to reduce local reactions. Antihistamines do not interfere with SCIT's immunologic mechanism. Because the PNW spring allergy season involves multiple overlapping allergens including red alder and PNW grasses, daily antihistamine use during the April–June period may be necessary regardless of SCIT status. Follow your prescribing allergist's protocol for antihistamine timing around injection visits.
Children can receive inhalant SCIT for Douglas fir provided they meet standard candidacy criteria: confirmed Pseudotsuga-specific IgE sensitization, inadequate symptom control with medications, and appropriate age. Most allergists begin SCIT no earlier than age 5–6. Because Douglas fir is classified as a non-major urban aeroallergen by major diagnostic labs, the bar for confirmed sensitization is higher — a pediatric allergist should confirm that the child has genuine Pseudotsuga-specific IgE (rather than cross-reactive Pinus or alder IgE) before initiating a multi-year injection program. Note: the Curex at-home pilot is currently open to patients age 12 and older; pediatric patients require a trained adult caregiver physically present for every injection. A large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots — though careful supervision of pediatric dosing remains essential.
For patients with confirmed sensitization to both Pseudotsuga and Pinus, separate vials are generally advisable because intra-Pinaceae cross-reactivity between the two genera is only partial. Complete cross-coverage cannot be assumed from a pine-mix vial for Pseudotsuga sensitization. Many PNW allergists who prescribe both Douglas fir and pine extracts will include them in the same vial set but confirm appropriate coverage at the concentrations used. Your prescribing allergist will determine the optimal vial composition based on your specific sensitization pattern and the extract manufacturer's technical specifications.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.